The Cigna Group (CI) Competitors

$341.50
-3.00 (-0.87%)
(As of 05/3/2024 ET)

CI vs. ELV, CNC, BSX, MDT, VRTX, REGN, BMY, GSK, SNY, and HCA

Should you be buying The Cigna Group stock or one of its competitors? The main competitors of The Cigna Group include Elevance Health (ELV), Centene (CNC), Boston Scientific (BSX), Medtronic (MDT), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Bristol-Myers Squibb (BMY), GSK (GSK), Sanofi (SNY), and HCA Healthcare (HCA). These companies are all part of the "medical" sector.

The Cigna Group vs.

Elevance Health (NYSE:ELV) and The Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk, institutional ownership and community ranking.

Elevance Health has higher earnings, but lower revenue than The Cigna Group. Elevance Health is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$171.34B0.71$5.99B$26.4619.92
The Cigna Group$195.27B0.51$5.16B$12.1828.04

Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. The Cigna Group pays an annual dividend of $5.60 per share and has a dividend yield of 1.6%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. The Cigna Group pays out 46.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 13 consecutive years and The Cigna Group has raised its dividend for 4 consecutive years.

Elevance Health presently has a consensus target price of $587.42, indicating a potential upside of 11.47%. The Cigna Group has a consensus target price of $366.14, indicating a potential upside of 7.22%. Given The Cigna Group's higher possible upside, equities analysts plainly believe Elevance Health is more favorable than The Cigna Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.92
The Cigna Group
0 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.92

Elevance Health has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, The Cigna Group has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500.

The Cigna Group received 97 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 71.86% of users gave The Cigna Group an outperform vote while only 66.61% of users gave Elevance Health an outperform vote.

CompanyUnderperformOutperform
Elevance HealthOutperform Votes
830
66.61%
Underperform Votes
416
33.39%
The Cigna GroupOutperform Votes
927
71.86%
Underperform Votes
363
28.14%

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 87.0% of The Cigna Group shares are owned by institutional investors. 0.4% of Elevance Health shares are owned by insiders. Comparatively, 0.6% of The Cigna Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 1.76%. The Cigna Group's return on equity of 20.62% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health3.64% 20.62% 7.35%
The Cigna Group 1.76%17.24%5.09%

In the previous week, The Cigna Group had 23 more articles in the media than Elevance Health. MarketBeat recorded 31 mentions for The Cigna Group and 8 mentions for Elevance Health. The Cigna Group's average media sentiment score of 1.38 beat Elevance Health's score of 0.62 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
The Cigna Group
12 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
2 Very Negative mention(s)
Positive

Summary

Elevance Health beats The Cigna Group on 13 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CI vs. The Competition

MetricThe Cigna GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$99.84B$65.05B$5.01B$17.50B
Dividend Yield1.64%1.38%2.90%3.53%
P/E Ratio28.0421.89240.8224.54
Price / Sales0.510.502,457.9310.46
Price / Cash9.5310.1050.1118.05
Price / Book2.413.554.905.52
Net Income$5.16B$3.04B$104.19M$964.63M
7 Day Performance-3.66%1.49%3.94%1.74%
1 Month Performance-5.78%2.99%-3.05%-1.66%
1 Year Performance30.97%7.30%4.22%103.32%

The Cigna Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.7769 of 5 stars
$528.58
-1.0%
$587.42
+11.1%
+15.4%$122.85B$171.34B19.98104,900Positive News
CNC
Centene
4.9368 of 5 stars
$73.06
-1.0%
$85.00
+16.3%
+11.3%$39.08B$154.00B14.5267,700Earnings Report
Analyst Report
Analyst Revision
BSX
Boston Scientific
4.3634 of 5 stars
$71.86
-0.9%
$75.09
+4.5%
+40.3%$105.43B$14.24B60.3948,000Insider Selling
MDT
Medtronic
4.7276 of 5 stars
$80.25
-0.8%
$94.91
+18.3%
-8.5%$106.56B$31.23B25.5695,000
VRTX
Vertex Pharmaceuticals
4.1739 of 5 stars
$392.81
-0.9%
$429.45
+9.3%
+15.7%$101.53B$9.87B28.285,400Upcoming Earnings
Analyst Upgrade
REGN
Regeneron Pharmaceuticals
3.872 of 5 stars
$890.66
-0.2%
$977.77
+9.8%
+26.9%$97.76B$13.12B25.6313,450Analyst Downgrade
Insider Selling
News Coverage
BMY
Bristol-Myers Squibb
4.9852 of 5 stars
$43.96
-1.5%
$60.00
+36.5%
-34.2%$89.11B$45.01B-14.1834,100Options Volume
GSK
GSK
3.0249 of 5 stars
$41.43
-0.4%
N/A+18.5%$85.86B$37.71B13.7670,200Dividend Increase
SNY
Sanofi
3.5794 of 5 stars
$49.23
+0.3%
$55.00
+11.7%
-10.5%$124.53B$46.61B24.7486,088
HCA
HCA Healthcare
4.685 of 5 stars
$309.80
-0.5%
$316.59
+2.2%
+10.9%$81.94B$64.97B15.44310,000Earnings Report
Dividend Announcement
Analyst Report
Analyst Revision

Related Companies and Tools

This page (NYSE:CI) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners